What is Ebola vaccine
Ebola vaccine candidates against Ebola have been developed in the decade prior to 2014, but none have yet been approved for clinical use in humans. Several promising vaccine candidates have been shown to protect nonhuman primates against lethal infection.
Symptoms of Ebola vaccine
A fever greater than 101.5 degrees Fahrenheit
Muscle pain
Severe headache
Weakness
Diarrhea
Vomiting
Abdominal pain
How is Ebola spread
Ebola is not an airborne virus. Unlike some other viruses, the Ebola virus can only be spread by body fluids. Therefore, Ebola spreads through human-to-human transmission via direct contact, according to WHO. bola is not spread through the air. This means that a person cannot contract the virus from breathing the same air as an infected individual. Direct contact means that blood, secretions, organs or other body fluids
containing the virus must come into contact with broken skin or the mucous membranes of a healthy individual in order for the virus to be transmitted.
WHO, common tests include the following
Virus isolation by cell culture
Antibody-capture enzyme-linked immunosorbent assay (ELISA)
Serum neutralization test
Antigen-capture detection tests
Electron microscopy
Reverse transcriptase polymerase chain reaction (RT-PCR) assay
Protect Against Deadly Virus
An experimental Ebola vaccine manufactured by Merck & Co. was found to be highly protective against the deadly virus, showing promise in the fight against future outbreaks after an earlier epidemic killed thousands and highlighted a shortage of weapons to battle the disease. The trial, called “Ebola ça Suffit” French for “Ebola that’s enough” was led by the WHO, Guinea’s Ministry of Health, Medecins sans Frontieres, the Norwegian Institute of Public Health, as well as other international partners.
Breakthrough Designation
The vaccine is called rVSV-ZEBOV and manufactured by Merck Sharp & Dohme, a subsidiary of the U.S. drugmaker. The disease spread had unexpectedly spiraled out of control, especially in the first few months, and public health officials initially struggled to curb the infections. The vaccine was initially engineered with support from the Public Health Agency of Canada.
Diagnosis of Ebola vaccine
CBC (Complete Blood Count)
Coagulation studies (a test to check for the amount of time a person’s blood needs to clot)
Viral antigen testing (a test to check for the presence of the viral antigen)
Liver function test
PREVENTION
Educate yourself about Ebola
Maintain sanitary conditions
Avoid contact with blood and body fluids
Treat injuries
Avoid crowded places
Use protective gear
Do not eat under-cooked meat
Avoid unnecessary trave
